title: Current status of veterinary vaccines.
abstract: The major goals of veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. These diverse aims have led to different approaches to the development of veterinary vaccines from crude but effective whole-pathogen preparations to molecularly defined subunit vaccines, genetically engineered organisms or chimeras, vectored antigen formulations, and naked DNA injections. The final successful outcome of vaccine research and development is the generation of a product that will be available in the marketplace or that will be used in the field to achieve desired outcomes. As detailed in this review, successful veterinary vaccines have been produced against viral, bacterial, protozoal, and multicellular pathogens, which in many ways have led the field in the application and adaptation of novel technologies. These veterinary vaccines have had, and continue to have, a major impact not only on animal health and production but also on human health through increasing safe food supplies and preventing animal-to-human transmission of infectious diseases. The continued interaction between animals and human researchers and health professionals will be of major importance for adapting new technologies, providing animal models of disease, and confronting new and emerging infectious diseases.
authors.affiliation: Animal Biotechnology Research Laboratories, Department of Physiology, Building 13f, Monash University, Clayton, Victoria 3800, Australia. els.meeusen@med.monash.edu.au
authors.forename: Els N T
authors.initials: EN
authors.lastname: Meeusen
authors.forename: John
authors.initials: J
authors.lastname: Walker
authors.forename: Andrew
authors.initials: A
authors.lastname: Peters
authors.forename: Paul-Pierre
authors.initials: PP
authors.lastname: Pastoret
authors.forename: Gregers
authors.initials: G
authors.lastname: Jungersen
mesh_terms: D000485:Allergens / Q000627:therapeutic use; D000820:Animal Diseases / Q000517:prevention & control*; D000818:Animals; D000829:Animals, Domestic; D001428:Bacterial Vaccines; D019496:Cancer Vaccines; D003140:Communicable Disease Control; D005298:Fertility; D006967:Hypersensitivity / Q000517:prevention & control; D009369:Neoplasms / Q000517:prevention & control; D016052:Protozoan Vaccines; D012098:Reproduction; D014611:Vaccination / Q000662:veterinary*; D014612:Vaccines; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
chemical_list: D000485:Allergens; D001428:Bacterial Vaccines; D019496:Cancer Vaccines; D016052:Protozoan Vaccines; D014612:Vaccines; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic; D014765:Viral Vaccines